EverSource Wealth Advisors LLC Has $47,000 Position in Privia Health Group, Inc. (NASDAQ:PRVA)

EverSource Wealth Advisors LLC raised its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 7,833.3% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 2,380 shares of the company’s stock after purchasing an additional 2,350 shares during the quarter. EverSource Wealth Advisors LLC’s holdings in Privia Health Group were worth $47,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of PRVA. Riverbridge Partners LLC grew its position in shares of Privia Health Group by 19.7% during the 4th quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company’s stock worth $113,868,000 after buying an additional 958,418 shares during the period. Eventide Asset Management LLC grew its position in shares of Privia Health Group by 979.2% during the 3rd quarter. Eventide Asset Management LLC now owns 822,438 shares of the company’s stock worth $14,977,000 after buying an additional 746,231 shares during the period. Icon Wealth Advisors LLC grew its position in shares of Privia Health Group by 1,910.1% during the 3rd quarter. Icon Wealth Advisors LLC now owns 300,889 shares of the company’s stock worth $5,479,000 after buying an additional 285,920 shares during the period. FMR LLC grew its position in shares of Privia Health Group by 1.5% during the 3rd quarter. FMR LLC now owns 18,169,043 shares of the company’s stock worth $330,858,000 after buying an additional 271,645 shares during the period. Finally, Barclays PLC grew its position in shares of Privia Health Group by 240.3% during the 3rd quarter. Barclays PLC now owns 224,018 shares of the company’s stock worth $4,079,000 after buying an additional 158,188 shares during the period. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have recently issued reports on PRVA. Needham & Company LLC boosted their target price on Privia Health Group from $25.00 to $30.00 and gave the stock a “buy” rating in a research report on Friday, February 28th. Stephens reiterated an “overweight” rating and issued a $26.00 price objective on shares of Privia Health Group in a research report on Thursday, January 2nd. JPMorgan Chase & Co. boosted their price objective on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research report on Friday, November 29th. Piper Sandler boosted their price objective on Privia Health Group from $25.00 to $40.00 and gave the company an “overweight” rating in a research report on Friday, February 28th. Finally, Canaccord Genuity Group boosted their price objective on Privia Health Group from $29.00 to $30.00 and gave the company a “buy” rating in a research report on Friday, February 28th. One analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $26.67.

Privia Health Group Trading Up 0.1 %

NASDAQ PRVA opened at $23.64 on Thursday. The company has a market cap of $2.85 billion, a PE ratio of 236.42, a PEG ratio of 3.47 and a beta of 0.85. Privia Health Group, Inc. has a 12 month low of $15.92 and a 12 month high of $26.04. The stock has a 50 day moving average of $23.54 and a 200-day moving average of $20.98.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.